NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV poses a higher risk of complications in adults, especially those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results